Back to top

Rapport Therapeutics, Inc. (RAPP) Receives a Buy from Citizens JMP

In a report released on July 8, Jason Butler from Citizens JMP reiterated a Buy rating on Rapport Therapeutics, Inc., with a price target of $28.00...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Rapport Therapeutics, Inc. (RAPP)